CASZ1 encodes a zinc finger transcription factor whose dysregulated expression was linked to the pathobiology of neuroblastoma [46], glioma [47], and hepatocellular carcinoma, and aberrant fusion transcripts of CASZ1 were reported in colorectal and bladder cancers [48]. This evidence concerns the gene CASZ1 and urinary bladder carcinoma.